Michael A. Metzger, CEO: Syndax Pharmaceuticals SNDX Sell · Filed 25/02/12

Trade details

Type: Insider sale
Amount: $205,964
Shares · price: 13,288 sh · $15.50 a share
Held after: 300,121 sh
Stock: Syndax Pharmaceuticals SNDX
Person: Michael A. MetzgerCEO
Trade date: 25/02/10
Filed: 25/02/12
Days to filing: 2 days

Sold 4.2% of holdings

Share of holding sold: 4.2%

Syndax Pharmaceuticals trades, last 26 weeks

What else happened in Syndax Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/01/11~25/03/12

Michael A. Metzger's recent trades

Michael A. MetzgerCEO
Planned sale10b5-1 planSyndax Pharmaceuticals
Planned sale10b5-1 plan
Syndax Pharmaceuticals
SNDX
$752.4K
32,375 sh
$752.4K
Filed 07/08
Traded 07/08
Michael A. MetzgerCEO
SellSyndax Pharmaceuticals
Sell
Syndax Pharmaceuticals
SNDX
$130K
6,847 sh
$130K
Filed 06/02
Traded 06/01
Michael A. MetzgerCEO
Planned saleSyndax Pharmaceuticals
Planned sale
Syndax Pharmaceuticals
SNDX
$130K
6,847 sh
$130K
Filed 06/01
Traded 06/01
Michael A. MetzgerCEO
SellSyndax Pharmaceuticals
Sell
Syndax Pharmaceuticals
SNDX
$360.9K
17,159 sh
$360.9K
Filed 02/10
Traded 02/09
Michael A. MetzgerCEO
Planned saleSyndax Pharmaceuticals
Planned sale
Syndax Pharmaceuticals
SNDX
$360.8K
17,159 sh
$360.8K
Filed 02/09
Traded 02/09